Skip to main content

Advertisement

Table 4 Trial outcomes in Routine F/U and Home F/U patients

From: Attrition in longitudinal randomized controlled trials: home visits make a difference

CARDIAC AND NEUROLOGIC MORBIDITY AND MORTALITY (N=248) P # OF COMPLICATIONS
Low MAP (n=124) 12.9%   Perioperative 13
  6 months 4
  Total 17
  0.026  
High MAP (n=124) 4.8%   Perioperative 4
   6 months 4
   Total 6
Total Cardiac and neurologic morbidity and mortality 8.9%   Total 22
Neurocognitive Dysfunction at 6 months (n=225)
Low MAP 12.4% 0.86 6 months 14
High MAP 11.6%   6 months 13
Total 12.0%    27
Functional Decline at 6 months (n=217)
Low MAP 8.3% 0.62 6 months 9
High MAP 6.5%   6 months 7
Total 7.4%    16
Combined Trial Outcome (n=248)
Low MAP 27.4% 0.032   34
High MAP 16.1%    20
Total 21.8%    54
  1. (Surveillance on 248 participants perioperatively and 237 participants at 6 months).
  2. MAP= Mean Arterial Pressure. Combined Trial Outcomes included the following complications at 6 months: cardiac morbidity (myocardial infarction, pulmonary edema, adult respiratory distress syndrome and cardiogenic shock); neurologic morbidity (major focal deficit); all-cause mortality; functional decline (>5 point decline in physical component summary measure of the SF-36); and neurocognitive deterioration (within-patient differences on an 11 test neurocognitive battery).